SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 54,000
-400 (-0.74%)
At close: Dec 5, 2025
SK bioscience Revenue
SK bioscience had revenue of 150.76B KRW in the quarter ending September 30, 2025, with 144.56% growth. This brings the company's revenue in the last twelve months to 624.03B, up 210.00% year-over-year. In the year 2024, SK bioscience had annual revenue of 267.55B, down -27.59%.
Revenue (ttm)
624.03B
Revenue Growth
+210.00%
P/S Ratio
6.78
Revenue / Employee
680.51M
Employees
917
Market Cap
4,231.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 267.55B | -101.96B | -27.59% |
| Dec 31, 2023 | 369.51B | -87.22B | -19.10% |
| Dec 31, 2022 | 456.73B | -472.28B | -50.84% |
| Dec 31, 2021 | 929.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition